Clinical Trials

Clinical trials are research studies that are designed to determine if a therapy is safe and effective for patients.

We are aiming to start a Phase 1 study to evaluate our lead Treg cell therapy candidate in patients with rheumatoid arthritis as soon as possible.

We are conducting a Phase 1 study of SBT-11-5301, our effector T cell-modulating biologic, in healthy participants.

For more information, visit ClinicalTrials.gov.